American Vietnamese Biotech (HSTC:AMV) Other Current Receivables: ₫0.00 Mil (As of . 20)


What is American Vietnamese Biotech Other Current Receivables?

American Vietnamese Biotech HSTC:AMV +7.69% Other Current Receivables is ₫0.00 Mil as of . 20.

American Vietnamese Biotech's Other Current Receivables for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Other Current Receivables Related Terms

American Vietnamese Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Other Current Receivables Chart

American Vietnamese Biotech Annual Data
Trend
Other Current Receivables

American Vietnamese Biotech Quarterly Data
Other Current Receivables

American Vietnamese Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a Other Current Receivables of ₫0.00 Mil as of . 20. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's Other Current Receivables too high?
American Vietnamese Biotech's current Other Current Receivables is ₫0.00 Mil.
How does American Vietnamese Biotech's Other Current Receivables compare to HSTC and STLT?
American Vietnamese Biotech's Other Current Receivables of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current Other Current Receivables is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Other Current Receivables of ₫0.00 Mil. The current Other Current Receivables is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Other Current Receivables is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.